Category:
Prophylactic Biological Products
CAS NO:
179324-69-7
Standard:
USP,
Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
Bortezomib is a proteasome inhibitor used in oncology. Its molecular formula is C16H25BN2O4 (CAS 179324-69-7). Core synthesis involves complex chiral coupling.
Requires strict cold chain storage at -20°C. Handle with PPE due to cytotoxicity; avoid inhalation and skin contact during compounding.